FDA Inspection
Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc.Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc. – FDA Inspection, Oct 27, 2008
Record Details
This FDA Inspection record concerns Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc., with an inspection on October 27, 2008, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- October 27, 2008
- Product Type
- Drugs
View Company Profile
ID · aa7226dd-7786-4208-a933-0b7eef45b04a
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 543370
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc.
11| Date | Classification | Office | Project area |
|---|---|---|---|
| September 20, 2024 | VAI | New Orleans District Office | Drug Quality Assurance |
| April 12, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 28, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 14, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 11, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.